Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Sage Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
SAGE
Nasdaq
2836
www.sagerx.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Sage Therapeutics, Inc.
Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary
- Jun 23rd, 2025 5:59 am
H.C. Wainwright sees potential competition for Sage from Biogen
- Jun 18th, 2025 7:45 am
SAGE to be Acquired by Supernus Pharmaceuticals in $795 Million Deal
- Jun 17th, 2025 12:36 pm
Sage Therapeutics (SAGE) Soars 35.4%: Is Further Upside Left in the Stock?
- Jun 17th, 2025 9:10 am
Morning Movers: Sage Therapeutics surges after deal to be acquired by Supernus
- Jun 17th, 2025 7:16 am
Supernus Pharmaceuticals Snaps Up Beleaguered Sage Therapeutics
- Jun 16th, 2025 2:21 pm
Sage Therapeutics Stock Soars 36% After Sale to Supernus Pharmaceuticals. What We Know.
- Jun 16th, 2025 10:27 am
Supernus makes depression drug play with $795m Sage buyout
- Jun 16th, 2025 9:43 am
Sector Update: Health Care Stocks Flat to Higher Premarket Monday
- Jun 16th, 2025 7:20 am
Sage, following setbacks, to sell to Supernus for $561M
- Jun 16th, 2025 6:17 am
Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio
- Jun 16th, 2025 5:00 am
Why Is Sage Therapeutics (SAGE) Down 11.1% Since Last Earnings Report?
- May 29th, 2025 9:30 am
Sage Therapeutics' Q1 Earnings Miss Mark, Revenue Rise Y/Y
- Apr 30th, 2025 10:17 am
Sage Therapeutics Inc (SAGE) Q1 2025 Earnings Call Highlights: Strong Demand for ZURZUVAE and ...
- Apr 30th, 2025 1:17 am
Sage Therapeutics, Inc. (SAGE) Reports Q1 Loss, Misses Revenue Estimates
- Apr 29th, 2025 3:15 pm
Sage Therapeutics Announces First Quarter 2025 Financial Results and Highlights Pipeline and Business Updates
- Apr 29th, 2025 2:05 pm
Analysts Estimate Agios Pharmaceuticals (AGIO) to Report a Decline in Earnings: What to Look Out for
- Apr 24th, 2025 8:02 am
Sage Therapeutics, Inc. (SAGE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
- Apr 22nd, 2025 8:01 am
Sage Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, April 29, 2025
- Apr 15th, 2025 4:30 am
Sage Therapeutics (SAGE) Up 7.4% Since Last Earnings Report: Can It Continue?
- Mar 13th, 2025 9:30 am
Scroll